品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | P126030-5mg | 5mg | 现货 | 483367-10-8 |
Purmorphamine,平滑受体激动剂 Purmorphamine |
Moligand™, ≥98% |
|
|
阿拉丁 | P126030-25mg | 25mg | 现货 | 483367-10-8 |
Purmorphamine,平滑受体激动剂 Purmorphamine |
Moligand™, ≥98% |
|
|
阿拉丁 | P126030-100mg | 100mg | 现货 | 483367-10-8 |
Purmorphamine,平滑受体激动剂 Purmorphamine |
Moligand™, ≥98% |
|
|
阿拉丁 | P126030-10mg | 10mg | 现货 | 483367-10-8 |
Purmorphamine,平滑受体激动剂 Purmorphamine |
Moligand™, ≥98% |
|
|
阿拉丁 | P424198-1ml | 1ml | 现货 | 483367-10-8 |
Purmorphamine Purmorphamine |
Moligand™, 2mM in DMSO |
|
|
麦克林 | P860863-10mg | 10mg | 订前询问 | 483367-10-8 |
Purmorphamine Purmorphamine |
>98% |
|
|
麦克林 | P860863-5mg | 5mg | 订前询问 | 483367-10-8 |
Purmorphamine Purmorphamine |
>98% |
|
|
麦克林 | P860863-25mg | 25mg | 订前询问 | 483367-10-8 |
Purmorphamine Purmorphamine |
>98% |
|
|
罗恩 | R026170-5mg | 5mg | 现货 | 483367-10-8 |
嘌呤胺 Purmorphamine |
98% |
|
|
罗恩 | R026170-10mg | 10mg | 5~7个工作日 | 483367-10-8 |
嘌呤胺 Purmorphamine |
98% |
|
|
MARY | MR137281-5mg | 5mg | 订前咨询 | 483367-10-8 |
嘌呤胺 Purmorphamine |
98% |
|
|
MARY | MR137281-10mg | 10mg | 订前咨询 | 483367-10-8 |
嘌呤胺 Purmorphamine |
98% |
|
|
源叶 | S47503-5mg | 5mg | 现货 | 483367-10-8 |
Purmorphamine Purmorphamine |
≥98% |
|
|
源叶 | S47503-10mg | 10mg | 现货 | 483367-10-8 |
Purmorphamine Purmorphamine |
≥98% |
|
|
源叶 | S47503-50mg | 50mg | 现货 | 483367-10-8 |
Purmorphamine Purmorphamine |
≥98% |
|
|
源叶 | T88595-1ml | 1ml | 期货,请咨询 | 483367-10-8 |
Purmorphamine Purmorphamine |
2mM in DMSO |
|
|
毕得 | BD305828-50mg | 50mg | 现货 | 483367-10-8 |
9-环己基-N-(4-吗啉苯基)-2-(萘-1-氧基)-... 9-Cyclohexyl-N-(4-morpholino... |
98% |
|
|
毕得 | BD305828-250mg | 250mg | 现货 | 483367-10-8 |
9-环己基-N-(4-吗啉苯基)-2-(萘-1-氧基)-... 9-Cyclohexyl-N-(4-morpholino... |
98% |
|
|
毕得 | BD305828-5mg | 5mg | 现货 | 483367-10-8 |
9-环己基-N-(4-吗啉苯基)-2-(萘-1-氧基)-... 9-Cyclohexyl-N-(4-morpholino... |
98% |
|
|
毕得 | BD305828-10mg | 10mg | 现货 | 483367-10-8 |
9-环己基-N-(4-吗啉苯基)-2-(萘-1-氧基)-... 9-Cyclohexyl-N-(4-morpholino... |
98% |
|
|